News Quantified

AGE – agex therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics [Yahoo! Finance]

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results [Yahoo! Finance]

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AGE, GRPH, FIXX

AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE

Form SC 13D/A AgeX Therapeutics, Inc. Filed by: Juvenescence Ltd

Form 10-K AgeX Therapeutics, Inc. For: Dec 31

Form 8-K AgeX Therapeutics, Inc. For: Mar 22

Form 8-K AgeX Therapeutics, Inc. For: Mar 14

Form 425 AgeX Therapeutics, Inc. Filed by: AgeX Therapeutics, Inc.

Top News Gainers

12/9 AgeX Therapeutics Issues Year-End Letter to Shareholders 23.0%

3/16 Form 8-K AgeX Therapeutics, Inc. For: Mar 12 19.4%

4/3 Form 4 AgeX Therapeutics, Inc. For: Apr 01 Filed by: Juvenescence Ltd 19.1%

1/14 AgeX Therapeutics to Participate at Four Conferences in January 2020 7.6%

10/18 Form 8-K AgeX Therapeutics, Inc. For: Oct 18 6.9%

8/5 Regenerative Medicine Leader Michael H. May Joins AgeX Board of Directors 6.6%

9/4 AgeX Therapeutics Publishes Theoretical Basis of Human Cell Age-Reversal in the Journal Regenerative Medicine 4.7%

11/21 Form 4 AgeX Therapeutics, Inc. For: Nov 19 Filed by: SEGALL JUDITH 4.2%

8/20 Form 3 AgeX Therapeutics, Inc. For: Aug 05 Filed by: MAY MICHAEL H 2.6%

9/10 Industry Leaders Aubrey De Grey And Frank Jaksch Join Yuva Biosciences Advisory Board 1.9%

Top News Decliners

5/15 Form 10-Q AgeX Therapeutics, Inc. For: Mar 31 -16.3%

8/14 Q2/2019 6/30/2019 EPS -0.080 ZacksConsensus N/A ActVsEst N/A - N/A -13.3%

4/6 Form SC 13D/A AgeX Therapeutics, Inc. Filed by: Juvenescence Ltd -11.7%

2/28 AgeX Therapeutics Researchers Publish Paper on the Age Reprogramming of Super-Centenarian Cells -11.5%

12/10 AgeX Therapeutics and Lineage Cell Therapeutics Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells -9.7%

3/31 Form 10-K/A AgeX Therapeutics, Inc. For: Dec 31 -9.3%

3/20 AgeX Therapeutics Licensee ImStem Biotechnology Announces FDA has Lifted the Hold and Cleared the Investigational New Drug Application for IMS001 for the Treatment of Multiple Sclerosis -8.8%

1/29 AgeX Therapeutics Enters Research Collaboration With Japanese Biopharma Company to Generate Hypoimmunogenic Cells -8.2%

10/3 Form 8-K AgeX Therapeutics, Inc. For: Sep 30 -7.5%

7/9 AgeX Therapeutics’ CEO Dr. Michael D. West to Present at Ending Age-Related Diseases: Investment Prospects & Advances in Research -7.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day